International Journal on Magnetic Particle Imaging IJMPI
Vol. 11 No. 1 Suppl 1 (2025): Int J Mag Part Imag

Short Abstracts

Signal characteristics of the clinically approved tracer Resotran in MPI and MRI

Main Article Content

Maria-Josephina Buhné (Institute of Radiology and Nuclear Medicine, University Hospital Luebeck Schleswig Holstein), Justin Ackers (Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany), Eric Aderhold (Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany), Kerstin Luedtke-Buzug (nstitute of Medical Engineering, University of Luebeck, Luebeck, Germany), Mandy Ahlborg (Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany), Matthias Graeser (Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany), Jonas Stroeder (Institute of Radiology and Nucelar Medicine, University Hospital Schleswig-Holstein, Luebeck, Germany), Roman Kloeckner (Institute of Interventional Radiology, University Hospital Schleswig-Holstein, Luebeck, Germany), Thorsten Buzug (Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany), Jörg Barkhausen (Institute of Radiology and Nucelar Medicine, University Hospital Schleswig-Holstein, Luebeck, Germany), Alex Frydrychowicz (Institute of Radiology and Nucelar Medicine, University Hospital Schleswig-Holstein, Luebeck, Germany), Franz Wegner (1)Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany; 2) Institute of Interventional Radiology, University Hospital Schleswig-Holstein, Luebeck, Germany)

Abstract

Potential medical applications for Magnetic Particle Imaging (MPI) are diverse. Especially, cardiovascular and cerebral perfusion imaging as well as the monitoring of endovascular interventions are very promising. With the approval of the Ferucarbotran-based tracer Resotran, a big hurdle on the way to clinical MPI has been overcome. A key characteristic of Resotran is the possibility of using it as a bimodal tracer for MPI and MRI. In this work, we tested the signal performance of Resotran in both preclinical MPI and clinical MRI.

Article Details

References

[1] Gräser M et la. Magnetic particle imaging: From research to the prospect of clinical use, Radiologie (Heidelb). 2022 Jun;62(6):496-503. German.
[2] Vaalma S et al., Magnetic particle imaging (MPI): ex- perimental quantification of vascular stenosis using stationary stenosis phantoms. PLoS ONE 12(1):e168902.
[3] Wegner F et al., Magnetic particle imaging: in vitro signal analysis and lumen quantification of 21 endovascular stents. Int J Nanomedicine 16:213–221.
[4] Mohn F al., Characterization of the clinically approved MRI tracer resotran for magnetic particle imaging in a comparison study, Phys. Med. Biol. 69 135014
[5] Biederer S et al., Magnetization response spectroscopy of superparamagnetic nanoparticles for magnetic particle imaging, J. Phys. D: Appl. Phys. 42 205007
[6] J. Franke et al., "Hybrid MPI-MRI System for Dual-Modal In Situ Cardiovascular Assessments of Real-Time 3D Blood Flow Quantification - A Pre-Clinical In Vivo Feasibility Investigation," in IEEE Transactions on Medical Imaging, vol. 39, no. 12, pp. 4335-4345, Dec. 2020 [7] P. Vogel et al., "MRI Meets MPI: A Bimodal MPI-MRI Tomograph," in IEEE Transactions on Medical Imaging, vol. 33, no. 10, pp. 1954-1959, Oct. 2014
[8] Salamon J et al., Visualization of spatial and temporal temperature distributions with magnetic particle imaging for liver tumor ablation therapy, Sci Rep (2020) 10:7480
[9] Wegner et al., Bimodal Interventional Instrument Markers for Magnetic Particle Imaging and Magnetic Resonance Imaging—A Proof of-Concept Study Nanomaterials 2022, 12(10),1758

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>